nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Pefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00465	0.161	CrCbGaD
Gemifloxacin—Enoxacin—CYP1A2—chronic obstructive pulmonary disease	0.00435	0.151	CrCbGaD
Gemifloxacin—Gatifloxacin—ALB—chronic obstructive pulmonary disease	0.00354	0.123	CrCbGaD
Gemifloxacin—Lomefloxacin—CYP1A2—chronic obstructive pulmonary disease	0.0033	0.114	CrCbGaD
Gemifloxacin—Levofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00282	0.0977	CrCbGaD
Gemifloxacin—Ofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00282	0.0977	CrCbGaD
Gemifloxacin—Ciprofloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00272	0.0943	CrCbGaD
Gemifloxacin—Norfloxacin—CYP1A1—chronic obstructive pulmonary disease	0.00237	0.0821	CrCbGaD
Gemifloxacin—Norfloxacin—CYP1A2—chronic obstructive pulmonary disease	0.00228	0.0792	CrCbGaD
Gemifloxacin—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00194	CcSEcCtD
Gemifloxacin—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00192	CcSEcCtD
Gemifloxacin—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00192	CcSEcCtD
Gemifloxacin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00186	0.00192	CcSEcCtD
Gemifloxacin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Gemifloxacin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Gemifloxacin—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00185	0.0019	CcSEcCtD
Gemifloxacin—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.0019	CcSEcCtD
Gemifloxacin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00184	0.00189	CcSEcCtD
Gemifloxacin—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00188	CcSEcCtD
Gemifloxacin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00181	0.00187	CcSEcCtD
Gemifloxacin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00186	CcSEcCtD
Gemifloxacin—Tremor—Formoterol—chronic obstructive pulmonary disease	0.0018	0.00185	CcSEcCtD
Gemifloxacin—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.00185	CcSEcCtD
Gemifloxacin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00185	CcSEcCtD
Gemifloxacin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00184	CcSEcCtD
Gemifloxacin—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00183	CcSEcCtD
Gemifloxacin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00183	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.00182	CcSEcCtD
Gemifloxacin—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00182	CcSEcCtD
Gemifloxacin—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00182	CcSEcCtD
Gemifloxacin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00181	CcSEcCtD
Gemifloxacin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00181	CcSEcCtD
Gemifloxacin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.0018	CcSEcCtD
Gemifloxacin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00176	CcSEcCtD
Gemifloxacin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00175	CcSEcCtD
Gemifloxacin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00175	CcSEcCtD
Gemifloxacin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00175	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00174	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00173	CcSEcCtD
Gemifloxacin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00171	CcSEcCtD
Gemifloxacin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00171	CcSEcCtD
Gemifloxacin—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00165	0.0017	CcSEcCtD
Gemifloxacin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Gemifloxacin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Gemifloxacin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Gemifloxacin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Gemifloxacin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00169	CcSEcCtD
Gemifloxacin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00168	CcSEcCtD
Gemifloxacin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00168	CcSEcCtD
Gemifloxacin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00168	CcSEcCtD
Gemifloxacin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00168	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00167	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00167	CcSEcCtD
Gemifloxacin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Gemifloxacin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Gemifloxacin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Gemifloxacin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Gemifloxacin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00165	CcSEcCtD
Gemifloxacin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00164	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00164	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00164	CcSEcCtD
Gemifloxacin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Gemifloxacin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Gemifloxacin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00159	CcSEcCtD
Gemifloxacin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00159	CcSEcCtD
Gemifloxacin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00159	CcSEcCtD
Gemifloxacin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Gemifloxacin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Gemifloxacin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Gemifloxacin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00158	CcSEcCtD
Gemifloxacin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00158	CcSEcCtD
Gemifloxacin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00158	CcSEcCtD
Gemifloxacin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00157	CcSEcCtD
Gemifloxacin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00157	CcSEcCtD
Gemifloxacin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00156	CcSEcCtD
Gemifloxacin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00155	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00155	CcSEcCtD
Gemifloxacin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00154	CcSEcCtD
Gemifloxacin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00153	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00153	CcSEcCtD
Gemifloxacin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00151	CcSEcCtD
Gemifloxacin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00146	0.0015	CcSEcCtD
Gemifloxacin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.0015	CcSEcCtD
Gemifloxacin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Gemifloxacin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00149	CcSEcCtD
Gemifloxacin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00148	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00147	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00147	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00147	CcSEcCtD
Gemifloxacin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Gemifloxacin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Gemifloxacin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00145	CcSEcCtD
Gemifloxacin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00145	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00144	CcSEcCtD
Gemifloxacin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00144	CcSEcCtD
Gemifloxacin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00144	CcSEcCtD
Gemifloxacin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00144	CcSEcCtD
Gemifloxacin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00144	CcSEcCtD
Gemifloxacin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00143	CcSEcCtD
Gemifloxacin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Gemifloxacin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Gemifloxacin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Gemifloxacin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00141	CcSEcCtD
Gemifloxacin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.0014	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Gemifloxacin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Gemifloxacin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Gemifloxacin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Gemifloxacin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00138	CcSEcCtD
Gemifloxacin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00138	CcSEcCtD
Gemifloxacin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00138	CcSEcCtD
Gemifloxacin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00138	CcSEcCtD
Gemifloxacin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00138	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00137	CcSEcCtD
Gemifloxacin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00136	CcSEcCtD
Gemifloxacin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00136	CcSEcCtD
Gemifloxacin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00136	CcSEcCtD
Gemifloxacin—Pain—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00135	CcSEcCtD
Gemifloxacin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00131	0.00135	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00134	CcSEcCtD
Gemifloxacin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Gemifloxacin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Gemifloxacin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Gemifloxacin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00133	CcSEcCtD
Gemifloxacin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00133	CcSEcCtD
Gemifloxacin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00129	0.00132	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00132	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00132	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00132	CcSEcCtD
Gemifloxacin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00132	CcSEcCtD
Gemifloxacin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.0013	CcSEcCtD
Gemifloxacin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.0013	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Gemifloxacin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00128	CcSEcCtD
Gemifloxacin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00128	CcSEcCtD
Gemifloxacin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00128	CcSEcCtD
Gemifloxacin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00128	CcSEcCtD
Gemifloxacin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00128	CcSEcCtD
Gemifloxacin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00128	CcSEcCtD
Gemifloxacin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00127	CcSEcCtD
Gemifloxacin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00126	CcSEcCtD
Gemifloxacin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00126	CcSEcCtD
Gemifloxacin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00126	CcSEcCtD
Gemifloxacin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00126	CcSEcCtD
Gemifloxacin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00125	CcSEcCtD
Gemifloxacin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00125	CcSEcCtD
Gemifloxacin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00125	CcSEcCtD
Gemifloxacin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00125	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00125	CcSEcCtD
Gemifloxacin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00124	CcSEcCtD
Gemifloxacin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00123	CcSEcCtD
Gemifloxacin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00121	CcSEcCtD
Gemifloxacin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00121	CcSEcCtD
Gemifloxacin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00121	CcSEcCtD
Gemifloxacin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00119	CcSEcCtD
Gemifloxacin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00119	CcSEcCtD
Gemifloxacin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00116	CcSEcCtD
Gemifloxacin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00116	CcSEcCtD
Gemifloxacin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Gemifloxacin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00114	CcSEcCtD
Gemifloxacin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00114	CcSEcCtD
Gemifloxacin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Gemifloxacin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00111	CcSEcCtD
Gemifloxacin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00111	CcSEcCtD
Gemifloxacin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00106	0.0011	CcSEcCtD
Gemifloxacin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00109	CcSEcCtD
Gemifloxacin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00108	CcSEcCtD
Gemifloxacin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00108	CcSEcCtD
Gemifloxacin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00107	CcSEcCtD
Gemifloxacin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00107	CcSEcCtD
Gemifloxacin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00105	CcSEcCtD
Gemifloxacin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00104	CcSEcCtD
Gemifloxacin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000998	0.00103	CcSEcCtD
Gemifloxacin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000998	0.00103	CcSEcCtD
Gemifloxacin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000989	0.00102	CcSEcCtD
Gemifloxacin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000989	0.00102	CcSEcCtD
Gemifloxacin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000988	0.00102	CcSEcCtD
Gemifloxacin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000988	0.00102	CcSEcCtD
Gemifloxacin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000983	0.00101	CcSEcCtD
Gemifloxacin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000983	0.00101	CcSEcCtD
Gemifloxacin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00098	0.00101	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000979	0.00101	CcSEcCtD
Gemifloxacin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000977	0.00101	CcSEcCtD
Gemifloxacin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000969	0.000998	CcSEcCtD
Gemifloxacin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000968	0.000997	CcSEcCtD
Gemifloxacin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000963	0.000991	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000949	0.000977	CcSEcCtD
Gemifloxacin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000942	0.00097	CcSEcCtD
Gemifloxacin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000935	0.000963	CcSEcCtD
Gemifloxacin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000934	0.000962	CcSEcCtD
Gemifloxacin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000934	0.000961	CcSEcCtD
Gemifloxacin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000933	0.000961	CcSEcCtD
Gemifloxacin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000932	0.00096	CcSEcCtD
Gemifloxacin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000932	0.00096	CcSEcCtD
Gemifloxacin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.000956	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000915	0.000942	CcSEcCtD
Gemifloxacin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000913	0.00094	CcSEcCtD
Gemifloxacin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00088	0.000906	CcSEcCtD
Gemifloxacin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000873	0.000899	CcSEcCtD
Gemifloxacin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000869	0.000895	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000854	0.000879	CcSEcCtD
Gemifloxacin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00085	0.000875	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00085	0.000875	CcSEcCtD
Gemifloxacin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000836	0.000861	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000829	0.000854	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000821	0.000846	CcSEcCtD
Gemifloxacin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000812	0.000836	CcSEcCtD
Gemifloxacin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000807	0.000831	CcSEcCtD
Gemifloxacin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000788	0.000812	CcSEcCtD
Gemifloxacin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000785	0.000808	CcSEcCtD
Gemifloxacin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000768	0.000791	CcSEcCtD
Gemifloxacin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000761	0.000784	CcSEcCtD
Gemifloxacin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000727	0.000748	CcSEcCtD
Gemifloxacin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000699	0.00072	CcSEcCtD
Gemifloxacin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00068	0.0007	CcSEcCtD
Gemifloxacin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000678	0.000699	CcSEcCtD
Gemifloxacin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000675	0.000695	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000665	0.000685	CcSEcCtD
Gemifloxacin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000644	0.000663	CcSEcCtD
Gemifloxacin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000644	0.000663	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00064	0.000659	CcSEcCtD
Gemifloxacin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000617	0.000636	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000617	0.000636	CcSEcCtD
Gemifloxacin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000607	0.000625	CcSEcCtD
Gemifloxacin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000606	0.000623	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000603	0.000621	CcSEcCtD
Gemifloxacin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.0006	0.000618	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000597	0.000615	CcSEcCtD
Gemifloxacin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000589	0.000606	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000563	0.000579	CcSEcCtD
Gemifloxacin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000562	0.000579	CcSEcCtD
Gemifloxacin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000558	0.000575	CcSEcCtD
Gemifloxacin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00056	CcSEcCtD
Gemifloxacin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000537	0.000553	CcSEcCtD
Gemifloxacin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000536	0.000552	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.000551	CcSEcCtD
Gemifloxacin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000532	0.000548	CcSEcCtD
Gemifloxacin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000532	0.000548	CcSEcCtD
Gemifloxacin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000528	0.000544	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000505	0.00052	CcSEcCtD
Gemifloxacin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000505	0.00052	CcSEcCtD
Gemifloxacin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00049	0.000505	CcSEcCtD
Gemifloxacin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000488	0.000503	CcSEcCtD
Gemifloxacin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000488	0.000503	CcSEcCtD
Gemifloxacin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000443	0.000456	CcSEcCtD
Gemifloxacin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000437	0.00045	CcSEcCtD
Gemifloxacin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000422	0.000435	CcSEcCtD
Gemifloxacin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000408	0.00042	CcSEcCtD
Gemifloxacin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000393	0.000404	CcSEcCtD
Gemifloxacin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000401	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000389	0.0004	CcSEcCtD
Gemifloxacin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000387	0.000398	CcSEcCtD
Gemifloxacin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000378	CcSEcCtD
